Co-developed by NYU Langone and Dana-Farber, the Solavia platform integrates EHR workflows, decision support, and pathway tracking for APPs and PAs.
|Videos|September 26, 2016
Meena Moran on Nurses and Nurse Navigators as Part of Multidisciplinary Care
Author(s)Meena Moran, MD
Meena Moran discusses the importance of nurses and nurse navigators when treating patients with cancer through a multidisciplinary approach.
Advertisement
Meena Moran, MD, from the Smilow Cancer Hospital at Yale-New Haven highlights the importance of nurses and nurse navigators as part of multidisciplinary care.
It is the nurses who form a strong connection and provide support for patients. This connection is vital when gathering information that contributes to a patient’s decision making. Nurse navigators also support the patient and reinforce recommendations from oncologists.
Advertisement
Related to this article
The FDA expands accelerated approval for sevabertinib to frontline HER2-mutant NSCLC, highlighting a need for vigilant nursing management of diarrhea.
FDA approves camizestrant for ESR1-mutated advanced breast cancer, tasking oncology nurses with guiding patients through ctDNA-based surveillance.
Dana Delaski, MSN, FNP-BC, shares insights on how once-daily ruxolitinib, self-injected rusfertide, and givinostat will transform PV clinic workflows.
The FDA has approved oral iberdomide (Zenbexus) for relapsed/refractory multiple myeloma, offering patients a highly potent, accessible therapy.
Oncology clinicians must actively champion NCCN guidelines as a critical pillar of breast cancer survivorship care,
With daraxonrasib approved for metastatic pancreatic cancer, Yolanda Justal, APRN, discusses essential nursing workflows for home-based care.
Beth Sandy, CRNP, of Penn Medicine explains how oncology nurses and pharmacists collaborate to manage financial toxicity and secure oral therapies.
Advertisement
Advertisement
Trending on Oncology Nursing News
1
FDA Approves Imlunestrant Plus Abemaciclib for ESR1-Mutated, ER-Positive, HER2-Negative Advanced Breast Cancer
2
Recognizing and Evaluating Diarrhea in Metastatic Triple-Negative Breast Cancer
3
WCLC 2026: Oncology Nursing Takeaways on Supportive Care and APP-Led Models
4
Gynecologic Cancer Awareness: Dr. Teplinsky Discusses Nursing Roles
5